Bain Capital Life Sciences Investors, LLC Insider Trading
Get free email notifications about insider trading for Bain Capital Life Sciences Investors, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bain Capital Life Sciences Investors, LLC. Bain Capital Life Sciences Investors, LLC is a 10% Owner in MARINUS PHARMACEUTICALS INC ($MRNS) and a 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Dicerna Pharmaceuticals Inc ($DRNA) and a 10% Owner in Annexon, Inc. ($ANNX) and a 10% Owner in Aptinyx Inc. ($APTX) and a 10% Owner in Replimune Group, Inc. ($REPL) and a 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and a 10% Owner in Arcutis Biotherapeutics, Inc. ($ARQT).
Address: 200 CLARENDON STREET BOSTON 02116 MA
Companies in which Bain Capital Life Sciences Investors, LLC is an Insider
Annexon, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bain Capital Life Sciences Investors, LLC: 10% Owner
Holdings: 2,522,385 shares
Latest Transaction: Jul 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aptinyx Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bain Capital Life Sciences Investors, LLC: 10% Owner
Holdings: 8,891,758 shares
Latest Transaction: Oct 27 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Arcutis Biotherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bain Capital Life Sciences Investors, LLC: 10% Owner
Holdings: 2,825,602 shares
Latest Transaction: Feb 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dicerna Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bain Capital Life Sciences Investors, LLC: 10% Owner, Director
Holdings: 5,580,237 shares
Current Value: $14,397,011
Latest Transaction: Nov 21 2019
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MARINUS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bain Capital Life Sciences Investors, LLC: 10% Owner
Holdings: 4,530,335 shares
Current Value: $5,481,705
Latest Transaction: Dec 19 2017
$MRNS Market Capitalization: $23.45M
$MRNS Previous Close: $1.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Replimune Group, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Bain Capital Life Sciences Investors, LLC: 10% Owner
Holdings: 2,338,968 shares
Latest Transaction: Jul 26 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SpringWorks Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Bain Capital Life Sciences Investors, LLC: 10% Owner
Holdings: 5,831,307 shares
Latest Transaction: Mar 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Bain Capital Life Sciences Investors, LLC
Sentiment: All, ANNX, APTX, ARQT, DRNA, MRNS, REPL, SWTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 2021 | SWTX | SpringWorks Therap ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 71.50 | 1,450,000 | 103,675,000 | 5,831,307 | 7.3 M to 5.8 M (-19.91 %) |
| Oct 27 2020 | APTX | Aptinyx Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 3.00 | 3,333,333 | 9,999,999 | 8,891,758 | 5.6 M to 8.9 M (+59.97 %) |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 2,812,543 | 0 | 0 | |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 22,222,221 | 0 | 0 | |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 17.00 | 400,000 | 6,800,000 | 3,241,628 | 2.8 M to 3.2 M (+14.08 %) |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 319,243 | 0 | 2,841,628 | 2.5 M to 2.8 M (+12.66 %) |
| Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 2,522,385 | 0 | 2,522,385 | 0 to 2.5 M |
View all Bain Capital Life Sciences Investors, LLC insider transactions.